Medicina, Free Full-Text

$ 7.00

4.5 (521) In stock

Breast cancer (BC) is considered the leading cause of death among females worldwide. Various risk factors contribute to BC development, such as age, genetics, reproductive factors, obesity, alcohol intake, and lifestyle. Obesity is considered to be a pandemic health problem globally, affecting millions of people worldwide. Obesity has been associated with a high risk of BC development. Determining the impact of obesity on BC development risk in women by demonstrating the molecular and genetic association in pre- and post-menopause females and risk to BC initiation is crucial in order to improve the diagnosis and prognosis of BC disease. In epidemiological studies, BC in premenopausal women was shown to be protective in a certain pattern. These altered effects between the two phases could be due to various physiological changes, such as estrogen/progesterone fluctuating levels. In addition, the relationship between BC risk and obesity is indicated by different molecular alterations as metabolic pathways and genetic mutation or epigenetic DNA changes supporting a strong connection between obesity and BC risk. However, these molecular and genetic alteration remain incompletely understood. The aim of this review is to highlight and elucidate the different molecular mechanisms and genetic changes occurring in obese women and their association with BC risk and development.

Finding Free Full-text PubMed Central Articles in PubMed

Bausch & Lomb Spectroscope - Science History Institute Digital

Medicina, Free Full-Text

Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation on X: 🔥🚨@OncoAlert Hot off the press Just published @NEJM in conjunction with presentation @myESMO #ESMO23 “Results of #DeLLphi301; Phase 2 trial of #Tarlatamab in #Patients with